Boston Biotech Firm Reports First Rise in 76 Years of Replikin Count* of H1N1 Lethality Gene
BOSTON, June 10, 2009 — An analysis of the latest peptide genomic data for the H1N1 influenza virus indicates that the current global outbreak of H1N1 is increasing in its capacity for lethality. The new seq…
First H1N1 Swine Flu Vaccine, Replikins-Based, Is Ready Now for Testing Worldwide
LONDON, May 4, 2009 — A synthetic peptide H1N1 vaccine is available now for testing worldwide, from Replikins Ltd. The company has developed the vaccine based on the same Replikins peptide technology which provided the surprise advance warning one year ago that the current H1N1 outbreak/pandem…
